Recent FEMY News
- Femasys Drives International Growth with Israeli Market Entry for Fertility Portfolio • GlobeNewswire Inc. • 04/16/2026 01:00:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/06/2026 08:01:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/01/2026 09:31:32 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/01/2026 09:19:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/01/2026 01:13:11 PM
- Femasys Appoints John Canning as Chief Operating Officer to Drive Operational Execution and Advance Commercial Growth • GlobeNewswire Inc. • 04/01/2026 01:00:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/31/2026 09:11:50 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2026 09:04:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/31/2026 08:18:51 PM
- Femasys Announces Financial Results for Year Ended December 31, 2025 and Provides Corporate Update • GlobeNewswire Inc. • 03/31/2026 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/27/2026 09:00:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/27/2026 09:00:25 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/27/2026 08:46:25 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 10:06:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/20/2026 10:38:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/20/2026 09:16:38 PM
- Femasys Appoints Dr. Kenneth D. Eichenbaum to Board of Directors • GlobeNewswire Inc. • 03/18/2026 01:00:00 PM
- Femasys Advances FemBloc Toward U.S. Approval with Initiation of Pivotal Trial Enrollment • GlobeNewswire Inc. • 03/10/2026 01:00:00 PM
- Femasys Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 02/27/2026 10:26:33 PM
- Femasys Announces FemBloc® Permanent Birth Control Has Achieved MDSAP Certification, Advancing Global Market Access • GlobeNewswire Inc. • 02/26/2026 02:00:00 PM
- Femasys Receives AMA CPT Editorial Panel Approval for New Category III CPT Code for FemaSeed Intratubal Insemination • GlobeNewswire Inc. • 02/23/2026 02:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2026 10:37:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/17/2026 10:47:34 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/17/2026 10:45:34 PM
- Femasys Expands European Commercial Footprint with Swiss Partner for FemBloc, FemaSeed, and Portfolio Products • GlobeNewswire Inc. • 02/03/2026 02:15:00 PM
